Neuroplasticity and Depressive Disorder Depressive disorder is associated with decreased neuroplasticity and decreased concentration of glutamate , which is a neurotransmitter of arousal. Some monoamines act on secondary messengers – mitogen- activated protein kinase , contribute to the
Depression is one of the not fully understood diseases. Its symptoms are: weight loss; weight gain; insomnia; psychomotor agitation; feeling of worthlessness, guilt. The main symptom
Patients with schizophrenia and depression have various structural changes in the brain. In schizophrenia, after the first episode of psychosis, the volume of gray matter in
Cytokines are protein molecules. Produced by cells of the thymus gland, immune system, spleen, blood. 90% of cytokines are secreted by B and T lymphocytes. Cytokines perform various
Evoked potential studies (auditory, cognitive, visual, sympathetic) show changes in the electrical activity of the brain in response to certain stimuli. The amplitude of the evoked
Selective serotonin reuptake inhibitors (SSRIs) are used to treat depression. Withdrawal symptoms may occur after treatment with these drugs. It can start suddenly. It will manifest itself as
In recent years, the science of optogenetics , a field of neurobiology , has been developing . Optical and genetic methods are used to study neural connections, neuronal excitation, and
Electroconvulsive therapy has a proven mechanism of action. When using it, the level of norepinephrine and other catecholamines in the hippocampus, frontal cortex, and basal ganglia